Foundation Medicine Shares Soar in First Day of Public Trading | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Foundation Medicine soared in their debut on the Nasdaq Global Select Market this morning.

The Cambridge, Mass.-based cancer genomics analysis firm said after the close of the market yesterday that it had launched its initial public offering of about 5.9 million shares at $18 per share.

In early Wednesday trade, the stock was up around 80 percent at $32.31.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.